Compass Therapeutics Inc. (CMPX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Compass Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$0.76
+1.73% today
Market cap
$135M
Overall quality
45/100
Kronos AI 30-day
—
Compass Therapeutics Inc. (CMPX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $135M. It trades at $0.76, up 1.73% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 11 analysts' average target of $6.11 implies +703.9% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.11 |
| Low – high | $1.00 – $12.00 |
| Analysts | 11 |
| Upside to average | +703.9% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 40 |
| Solvency | 60 |
| Growth | 35 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.